| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Lidocaine^>45m post bolus dose | LP307944-1 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | Lidocaine | Serum or Plasma | Drug toxicology | LP389194-4 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | ug/mL | |
| EXAMPLE_UCUM_UNITS | ug/mL | |
| UNITSREQUIRED | Y |
| LONG_COMMON_NAME | en-US | Lidocaine [Mass/volume] in Serum or Plasma -->45 minutes post bolus dose |
| LONG_COMMON_NAME | en-US | Lidocaine [Mass/volume] in Serum or Plasma -->45 minutes post bolus dose |
| SHORTNAME | en-US | Lidocain >45M p bol SerPl-mCnc |
| ConsumerName | en-US | Lidocaine >45 min after Bolus dose, Blood |
| SHORTNAME | es-AR | lidocaína^>45 minutos después de dosis en bolo:concentración de masa:punto en el tiempo:suero/plasma:cuantitativo: |
| SHORTNAME | pt-BR | Lidocain >45M p bol SerPl-mCnc |
| LONG_COMMON_NAME | fr-FR | Lidocaïne T45min après administration en bolus [Masse/Volume] Sérum/Plasma ; Numérique |
| LONG_COMMON_NAME | nl-NL | Lidocaïne^>45 min na bolusdosering [massa/volume] in serum of plasma |
| LONG_COMMON_NAME | es-MX | Lidocaína : Suero o Plasma : Punto temporal: Concentración de masa: Cuantitativo: |
LOINC Version: 2.77
FHIR